Aflibercept
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4181 publications
Retinal anti-VEGF treatment now, and what next? From loading doses to long-game thinking.
Journal: Expert opinion on pharmacotherapy
Published: June 24, 2026
Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study.
Journal: Journal of vitreoretinal diseases
Published: June 23, 2026
Long-Term Outcomes and Predictors of Response to Anti-VEGF Therapy for Diabetic Macular Edema in Clinical Practice.
Journal: Journal of visualized experiments : JoVE
Published: June 22, 2026
Trends in the Initial Treatment for Retinopathy of Prematurity in the United States.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: June 18, 2026
Worsening abducens paresis and chronic orbital venous congestion after carotid-cavernous fistula embolization: long-term motility outcomes.
Journal: Strabismus
Published: June 17, 2026
Eye Drop Development of Anti-VEGF Therapeutics by Ocular Penetrating Carrier to the Posterior Region of the Eye.
Journal: Translational vision science & technology
Published: June 03, 2026
Difference in Ocular Perfusion Drop After Intravitreal Aflibercept in Patients with Neovascular AMD and Diabetic Macular Edema.
Journal: Current eye research
Published: June 02, 2026
Comparison of Intraocular Inflammation Associated with High-Dose Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Real-World Disproportionality Analysis.
Journal: Ocular immunology and inflammation
Published: June 01, 2026
Real-World Outcomes after Switch to Aflibercept 8 mg in Neovascular AMD: Twelve Months Follow-up on 654 Eyes.
Journal: Retina (Philadelphia, Pa.)
Published: May 26, 2026
Comment to: Hashiya N, Maruko I, Maruko R et al. Increased intraocular pressure immediately after aflibercept 8 mg intravitreal injection for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2026) 264:1611-1617. doi:10.1007/s00417-026-07117-3.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: May 26, 2026
Impact of Aflibercept Dosing Frequency on Retinal Nonperfusion Progression Assessed by Ultra-Widefield Angiography After Endolaserless Vitrectomy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.
Journal: Journal of vitreoretinal diseases
Published: May 21, 2026
Longitudinal Multi-Omics Profiling of Aqueous Humor Implicates GALNS Depletion as a Pro-Fibrotic Mediator of Anti-VEGF Therapy in PDR.
Journal: Investigative ophthalmology & visual science
Published: May 18, 2026
Last Updated: 06/30/2026